RIKEN announced that the Institute's Scientific Research Center immunological sensitivity of Ishikawa Fumihiko and small income, who originally formed a joint research team found 25 species present in leukemia stem cells, can cause the main elements of leukemia relapse. Based on this discovery, scientists are able to develop protect normal blood stem cells, leukemia stem cells only target of new drugs, in order to cure leukemia, from the liver cells provides a basis to proceed. The research is published in the February 3 the United States "Science Translational Medicine" magazine's online edition.
Acute myelogenous leukemia is mainly in the adults, a malignant cancer of the blood.Although to date has developed a variety of anti-cancer drugs, can be reduced or symptoms of leukemia cells to improve the results. However, in patients with recurrent disease will be until death, it is still the greatest difficulties the treatment of leukemia.
Research team in the previous study found that because of relapse of leukemia stem cells in the bone marrow in a special place, and thus have anti-cancer drug resistance.
To read more click HERE to go to the original webpage.